AIDS MDT

HIV-infected patients experience impaired cellular immune function, making them highly susceptible to various complications such as opportunistic infections and opportunistic cancers. These conditions can affect every system in the body, severely impacting patient prognosis.

The AIDS MDT care model addresses the medical need for "comprehensive, long-term management of HIV/AIDS as a chronic internal medicine condition," while also aligning with the current policy direction from health administrative departments at all levels—encouraging large, comprehensive hospitals to actively engage in HIV prevention and control efforts. A well-established, multidisciplinary team is a key strength that enables large, integrated hospitals to play a pivotal role in combating HIV/AIDS. Currently, at the university level, our hospital has taken the lead in collaborating with various relevant colleges to launch comprehensive HIV prevention and control research. This initiative has resulted in the development of effective HIV prevention strategies and the establishment of a dedicated research platform focused on HIV control. As a critical component of this integrated prevention and control framework, the implementation of the AIDS MDT approach has significantly enhanced our hospital's capacity to provide holistic care and treatment for HIV patients, offering patients superior healthcare options and improving their overall health management.

HIV diagnostic test report, HIV RNA test report, absolute counts of T lymphocyte subsets, self-paid or free antiviral treatment regimen, complete blood count, pre-transfusion comprehensive panel, blood biochemistry 1+4 (liver, kidney, glucose, lipids, enzymes, electrolytes), CRP/IL-6/PCT, preoperative coagulation profile, and chest imaging studies. For patients suspected of or diagnosed with HIV-associated lymphoma, additional tests include HBV DNA, EBV DNA, β2-microglobulin, absolute NK cell count, ECG, and PET-CT.

1. Expert Team

Infectious Disease Center: Tang Ta, Feng Kan, Bai Kan, Chen Ruo, Wang Qian, Du Gaoxue

Hematology Department: Niu Ting, Ji Jie, Dong Ta

Pathology Department: Liu Weiping, Zhao Hao

Clinical Nutrition Department: Hu Wen, Rao Fa

Mental Health Center: Approaches to Well-being

Nuclear Medicine Department: Su Brings Back

Head and Neck Oncology Department: Xie Hui

II. Conditions Required for Patients to Attend the MDT Consultation

1. Age over 14 at the time of consultation, diagnosed with HIV infection;

2. Diagnosis or suspicion of AIDS-defining tumors, as well as non-AIDS-defining tumors;

3. Diagnosis or suspicion of HIV/AIDS complicated by opportunistic infections;

4. Diagnosing fever of unknown origin;

5. Accompanied by severe psychological disorders;

6. Accompanied by severe malnutrition;

7. Pre- and post-exposure prophylaxis counseling;

8. Prevention and mother-to-child transmission counseling for single-parent families;

Meet any one of items 1 through 6, or satisfy either item 7 or 8.

3. Patient Visit Process

1. Relevant specialist doctors recommend appointments based on the patient’s condition; staff at the consultation center verify and organize the relevant medical records, then inform patients of the specific time and location for their outpatient visit.

2. The MDT team contact person is responsible for reviewing the patient’s medical history, gathering and organizing relevant information, and presenting the case to outpatient specialists. After a multidisciplinary team discussion, treatment decisions are made, and the patient and their family are informed of the diagnosis and treatment plan. Finally, the outpatient report is shared with them.

IV. Notes for Your Visit

1. Outpatient Hours : Starts every other Monday at 4:30 PM

2. Outpatient Clinic Location : Infectious Diseases Center, HIV Care and Follow-up Office, 1st Floor of the Isolation Ward

3. Fee Structure : $270 per session

4. Contact Phone Number : 028-8***2219

5. The patient arrives at the consultation site one hour early. When attending the outpatient appointment, patients must bring all their relevant examination records.

HIV确诊 test report, HIV RNA test report, absolute counts of T lymphocyte subsets, self-paid or free antiviral treatment regimen, complete blood count, pre-transfusion comprehensive panel, blood biochemistry 1+4 (liver, kidney, glucose, lipids, enzymes, electrolytes), CRP/IL-6/PCT, preoperative coagulation profile, and chest imaging studies. For patients suspected of or diagnosed with HIV-associated lymphoma, additional tests include HBV DNA, EBV DNA, β2-microglobulin, absolute NK cell count, ECG, and PET-CT.